The Octanate® immune tolerance induction experience in haemophilia A patients with inhibitors and a poor prognosis:: prospective post-marketing study in progress

被引：0
|
作者：
Zozulya, N. I. . [1 ]
Plyushch, O. P. [1 ]
Severova, T. V. [1 ]
机构：
[1] Moscow Hemophilia Ctr, Moscow, Russia
来源：
HAEMOPHILIA | 2008年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：150 / 150
页数：1
相关论文
共 50 条
  • [1] The Octanate® immune tolerance induction experience in haemophilia A patients with inhibitors and poor prognosis:: prospective post-marketing study in progress
    Zozulya, N.
    Plyushch, O.
    Severova, T.
    HAEMOPHILIA, 2008, 14 : 51 - 51
  • [2] Immune tolerance induction with Octanate® in haemophilia A patients with inhibitors and a poor prognosis: progress report on an ongoing prospective data collection
    Zozulya, N.
    Plyushch, O.
    Vdovin, V.
    Svirin, P.
    Andreeva, T.
    Dolnicar, M. Benedik
    Severova, T.
    Klimova, N.
    Escuriola, C.
    Kreuz, W.
    HAEMOPHILIA, 2010, 16 : 41 - 41
  • [3] Treatment of haemophilia A patients with inhibitors and a poor prognosis: ITI with octanate® Zozulya NI
    Zozulya, N., I
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 1127 - 1127
  • [4] ITI with a VWF/FVIII concentrate in haemophilia a patients with inhibitors and a poor prognosis for ITI success: progress report on Octanate in the Obsiti study
    Zozulya, N.
    Plyushch, O.
    Vdovin, V.
    Andreeva, T.
    Svirin, P.
    Severova, T.
    Shiller, E.
    Klimova, N.
    Dolnicar, M. B.
    Velasco, F.
    Campos, M.
    Morais, S.
    Ettingshausen, C. E.
    Kreuz, W.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 825 - 826
  • [5] ITI with a VWF/FVIII concentrate in haemophilia a patients with inhibitors and a poor prognosis for ITI success: progress report on OCTANATE® in the obsiti study
    Escuriola-Ettingshausen, C.
    Kreuz, W.
    HAEMOPHILIA, 2013, 19 : 48 - 49
  • [6] Immune tolerance induction with antihaemophilia factor (human) in poor prognosis patients with haemophilia A
    Escobar, Miguel
    Shaffer, Linda
    Holguin, Mark
    McCavit, Timothy
    Amega, Novinyo S.
    Rajan, Sandeep K.
    HAEMOPHILIA, 2021, 27 (03) : E393 - E397
  • [7] ITI with a VWF/FVIII concentrate in haemophilia A patients with inhibitors and a poor prognosis for ITI success: Octanate® in the ObsITI study
    Escuriola, C.
    Kreuz, W.
    Schwartz, B.
    HAEMOPHILIA, 2013, 19 (03) : 466 - 466
  • [8] Immune Tolerance Induction in paediatric patients with severe Haemophilia A with inhibitors: Malaysian experience
    Salim, Nik Nabilah Nik Mohd
    HAEMOPHILIA, 2020, 26 : 33 - 33
  • [9] ITI with a VWF stabilised FVIII concentrate in haemophilia A patients with inhibitors and a poor prognosis for ITI success: progress report on Octanate® in the observational ObsITI study
    Ettingshausen, C. Escuriola
    Zozulya, N.
    Plyushch, O.
    Vdovin, V.
    Andreeva, T.
    Svirin, P.
    Severova, T.
    Shiller, E.
    Klimova, N.
    Benedik-Dolnicar, M.
    Velasco, F.
    Campos, M.
    Morais, S.
    Kreuz, W.
    HAEMOPHILIA, 2012, 18 : 13 - 14
  • [10] ITI with a VWF-stabilised FVIII concentrate in haemophilia a patients with inhibitors and a poor prognosis for ITI success: progress report on octanate in the observational obsiti study
    Zozulya, N.
    Plysch, O.
    Vdovin, V.
    Andreeva, T.
    Svirin, P.
    Severova, T.
    Shiller, E.
    Klimova, N.
    Benedik-Dolnicar, M.
    Velasco, F.
    Campos, M.
    Bichler, J.
    Escuriola, C.
    Kreuz, W.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 30 - 31
12345